Literature DB >> 3263168

The histological effects of intracerebral injection or infusion of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and MPP+ (1-methyl-4-phenylpyridinium) in rat and mouse.

W R Gibb1, B Costall, A M Domeney, M E Kelly, R J Naylor.   

Abstract

Bilateral infusion of MPTP into the substantia nigra, ventral tegmental area or putamen of the rat brain provoked accumulation of leucocytes, but the periphery of nigral lesions showed no significant nerve cell loss. Tyrosine hydroxylase labelling of dopaminergic perikarya showed a normal staining pattern. In contrast, MPP+ was more destructive. After one day there was local degeneration of neuronal and glial elements. After one month there was tissue necrosis and central cavitation, but, like MPTP, there was no evidence of selective nigral cell loss. Striatal injection of MPP+ also failed to produce retrograde nigral damage. It is concluded that the toxicity of MPP+ applied directly to the dopamine system is a consequence of a severe non-selective necrotic lesion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263168     DOI: 10.1016/0006-8993(88)90268-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  MPP+ toxicity in rat striatal slices: relationship between non-selective effects and free radical production.

Authors:  S Ambrosio; A Espino; B Cutillas; R Bartrons
Journal:  Neurochem Res       Date:  1996-01       Impact factor: 3.996

2.  Intrastriatal grafts of fetal mesencephalic cell suspensions in MPP+-lesioned rats: a microdialysis study in vivo.

Authors:  M Espejo; S Ambrosio; J Llorens; B Cutillas
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

3.  Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells.

Authors:  Keith Chiasson; Benoît Daoust; Daniel Levesque; Maria-Grazia Martinoli
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.